Transfection and luciferase reporter assay

YQ Yongli Qin
LJ Lina Jia
HL Huijiao Liu
WM Wenqiang Ma
XR Xinmin Ren
HL Haifeng Li
YL Yuanwu Liu
HL Haiwen Li
SM Shuoqian Ma
ML Mei Liu
PL Pingping Li
JY Jinghua Yan
JZ Jiyan Zhang
YG Yangdong Guo
HY Hua You
YG Yan Guo
NR Nafis A. Rahman
SW Sławomir Wołczyński
AK Adam Kretowski
DL Dangsheng Li
XL Xiru Li
FR Fazheng Ren
XL Xiangdong Li
request Request a Protocol
ask Ask a question
Favorite

HeLa cells (2 × 104 cells per well) were seeded into 96-well plates and were transfected after 24 h with expression vectors and luciferase reporter genes by using Lipofectamine 3000 (Invitrogen, USA). The transfection procedure was performed as described in a previous study74. In brief, 20 ng/well pGL3/NF-κB-luc reporter gene combined with 25 ng/well pcDNA3.1/FLAG-MyD88, or 10 ng/well pcDNA3.1/FLAG-TRAF6, or 10 ng/well pcDNA3.1/FLAG-p65 plasmids, and PC2AOE-3×FLAG-NOC4L expression plasmids in different amounts (0, 30, 60 ng) or PC2AOE-GFP plasmid, was co-transfected into the cells. Similarly, 20 ng/well pGL3/NF-κB-luc reporter genes combined with 20 ng/well pcDNA4.0-TRIF and PC2AOE-3×FLAG-NOC4L expression plasmids in different amounts (0, 25, 50, and 100 ng) or PC2AOE-GFP plasmid were co-transfected into the cells. In addition, 10 ng/well of the phRL-TK reporter plasmid (Promega, USA) was co-transfected to allow normalization of data for transfection efficiency. The total amount of DNA per transfection was kept constant at 150 ng by adding the empty vector PC2AOE-3×FLAG. After transfection for 24 h, luciferase activity was measured using a Dual-Luciferase reporter assay system (Promega, USA) following the instructions provided by the manufacturer. The luciferase activity was normalized against Renilla luciferase activity. All reporter assays were completed in 4 repeat wells, and data were presented as mean ± SEM.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A